BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16155077)

  • 1. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH.
    Abdalla H; Thum MY
    Hum Reprod; 2006 Jan; 21(1):171-4. PubMed ID: 16155077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
    Abdalla H; Thum MY
    Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Carmona F; Casamitjana R; Vanrell JA; Balasch J
    Hum Reprod; 2005 Mar; 20(3):622-8. PubMed ID: 15608035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High live birth rate in the subsequent IVF cycle after first-cycle poor response among women with mean age 35 and normal FSH.
    Moolenaar LM; Mohiuddin S; Munro Davie M; Merrilees MA; Broekmans FJ; Mol BW; Johnson NP
    Reprod Biomed Online; 2013 Oct; 27(4):362-6. PubMed ID: 23953583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of body mass index to in-vitro fertilisation treatment outcome, risk of miscarriage and pregnancy outcome.
    Thum MY; El-Sheikhah A; Faris R; Parikh J; Wren M; Ogunyemi T; Gafar A; Abdalla H
    J Obstet Gynaecol; 2007 Oct; 27(7):699-702. PubMed ID: 17999296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of elevated basal follicle-stimulating hormone on the quantity and quality of oocytes and embryos and pregnancy outcomes in young women].
    Chen SL; Luo YQ; Xia R; Chen X; Shi XY; Zheng HY; Wang LL; Wu YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):777-81. PubMed ID: 21602123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
    Hendriks DJ; Broekmans FJ; Bancsi LF; de Jong FH; Looman CW; Te Velde ER
    Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between women's age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment.
    Thum MY; Abdalla HI; Taylor D
    Fertil Steril; 2008 Aug; 90(2):315-21. PubMed ID: 17953958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
    Datta AK; Zosmer A; Tozer A; Sabatini L; Davis C; Al-Shawaf T
    Reprod Biomed Online; 2012 May; 24(5):503-10. PubMed ID: 22417663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FSH and IVF management: the best and worst case scenarios].
    Aubriot FX; Chapron C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):636-40. PubMed ID: 18538623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IVF treatment should not be postponed for patients with high basal FSH concentrations.
    Maman E; Baum M; Machtinger R; Seidman DS; Dor J; Hourvitz A
    Reprod Biomed Online; 2010 Nov; 21(5):631-5. PubMed ID: 20864411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone.
    Scott RT; Elkind-Hirsch KE; Styne-Gross A; Miller KA; Frattarelli JL
    Fertil Steril; 2008 Apr; 89(4):868-78. PubMed ID: 17603049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction.
    Brodin T; Bergh T; Berglund L; Hadziosmanovic N; Holte J
    Hum Reprod; 2009 Nov; 24(11):2755-9. PubMed ID: 19617206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization.
    Luna M; Grunfeld L; Mukherjee T; Sandler B; Copperman AB
    Fertil Steril; 2007 Apr; 87(4):782-7. PubMed ID: 17207802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor responders in IVF: cancellation of a first cycle is not predictive of a subsequent failure.
    Baka S; Makrakis E; Tzanakaki D; Konidaris S; Hassiakos D; Moustakarias T; Creatsas G
    Ann N Y Acad Sci; 2006 Dec; 1092():418-25. PubMed ID: 17308168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
    Ng EH; Chan CC; Tang OS; Ho PC
    Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles.
    Klinkert ER; Broekmans FJ; Looman CW; Te Velde ER
    Fertil Steril; 2004 May; 81(5):1247-53. PubMed ID: 15136085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
    Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.